Literature DB >> 6323539

Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro.

H H Salem, N L Esmon, C T Esmon, P W Majerus.   

Abstract

Protein C activation by thrombin is significantly accelerated by the endothelial cell surface protein thrombomodulin, Factor Va, or its light chain. In this study we have compared the activation of protein C in the presence of either cofactor and examined the possibility that thrombomodulin and Factor Va-light chain act together to regulate protein C activation by thrombin. At all concentrations of protein C used, thrombomodulin was 20 times more efficient than Factor Va-light chain in accelerating protein C activation by thrombin. Protein C treated with chymotrypsin to remove the amino-terminal 41 amino acids that contain the gamma-carboxyglutamyl residues was activated by the thrombin-thrombomodulin complex at an identical rate to native protein C, whereas the modified protein C was activated by Factor Va-light chain and thrombin at only 5% of the rate obtained by using native protein C. Increasing concentrations of Factor Va-light chain, greater than or equal to 30 nM, inhibited thrombin-thrombomodulin catalyzed protein C activation with complete inhibition observed at 90 nM Factor Va-light chain. On the other hand, increasing thrombomodulin concentrations did not inhibit protein C activation by Factor Va-light chain and thrombin. These reactions in solution mimic, in part, those obtained on endothelial cells where protein C lacking the gamma-carboxyglutamyl domain is activated poorly and Factor Va-light chain at concentrations greater than 50 nM inhibited the activation of native protein C. The results of this study suggest that thrombomodulin and Factor Va-light chain may act in concert to regulate protein C activation by thrombin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323539      PMCID: PMC425108          DOI: 10.1172/JCI111321

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity.

Authors:  C T Esmon
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

2.  Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.

Authors:  N L Esmon; W G Owen; C T Esmon
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

3.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

4.  The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

Authors:  F J Walker; P W Sexton; C T Esmon
Journal:  Biochim Biophys Acta       Date:  1979-12-07

5.  Purification and characterization of human coagulation factor V.

Authors:  W H Kane; P W Majerus
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

6.  The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin.

Authors:  W G Owen; C T Esmon; C M Jackson
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

7.  Properties of the factor Xa binding site on human platelets.

Authors:  J P Miletich; C M Jackson; P W Majerus
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

8.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.

Authors:  C T Esmon; N L Esmon; K W Harris
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

9.  Evidence for the formation of an ester between thrombin and heparin cofactor.

Authors:  W G Owen
Journal:  Biochim Biophys Acta       Date:  1975-10-20

10.  Activation of protein C in vivo.

Authors:  P C Comp; R M Jacocks; G L Ferrell; C T Esmon
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

View more
  8 in total

1.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.

Authors:  W H Kane; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Inhibition of activated protein C by platelets.

Authors:  S M Jane; C A Mitchell; L Hau; H H Salem
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Cleavage of protein S by a platelet membrane protease.

Authors:  C A Mitchell; H H Salem
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 4.  The haemostatic function of the vascular endothelial cell.

Authors:  H A Bull; S J Machin
Journal:  Blut       Date:  1987-08

Review 5.  Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.

Authors:  B Dahlbäck
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex.

Authors:  J M Freyssinet; J Gauchy; J P Cazenave
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

7.  Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.

Authors:  I Maruyama; H H Salem; H Ishii; P W Majerus
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

8.  Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation.

Authors:  I Maruyama; H H Salem; P W Majerus
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.